ECT2 associated to PRICKLE1 are poor-prognosis markers in triple-negative breast cancer

BACKGROUND: Triple-negative breast cancers (TNBC) are poor-prognosis tumours candidate to chemotherapy as only systemic treatment. We previously found that PRICKLE1, a prometastatic protein involved in planar cell polarity, is upregulated in TNBC. We investigated the protein complex associated with...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Br J Cancer
Hauptverfasser: Daulat, Avais M., Finetti, Pascal, Revinski, Diego, Silveira Wagner, Mônica, Camoin, Luc, Audebert, Stéphane, Birnbaum, Daniel, Kodjabachian, Laurent, Borg, Jean-Paul, Bertucci, François
Format: Artigo
Sprache:Inglês
Veröffentlicht: Nature Publishing Group UK 2019
Schlagworte:
Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6734648/
https://ncbi.nlm.nih.gov/pubmed/30971775
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41416-019-0448-z
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge